bispecific IGFR1/EGFR antibody (Glycart)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namebispecific IGFR1/EGFR antibody (Glycart)
Drug Alias NameOAscFab-IgGXGFR-2421XGFR1-2421
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsEpidermal growth factor receptor erbB1 antagonistsAnticancer protein kinase inhibitors
TargetsInsulin-like growth factor I receptorEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Glycart Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Glycart Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A